Suchen und Finden

Titel

Autor

Inhaltsverzeichnis

Nur ebooks mit Firmenlizenz anzeigen:

 

Biological and Bio-inspired Nanomaterials - Properties and Assembly Mechanisms

Biological and Bio-inspired Nanomaterials - Properties and Assembly Mechanisms

Sarah Perrett, Alexander K. Buell, Tuomas P.J. Knowles

 

Verlag Springer-Verlag, 2019

ISBN 9789811397912 , 439 Seiten

Format PDF, OL

Kopierschutz Wasserzeichen

Geräte

160,49 EUR

Mehr zum Inhalt

Biological and Bio-inspired Nanomaterials - Properties and Assembly Mechanisms


 

Contents

5

1 Dynamics and Control of Peptide Self-Assembly and Aggregation

7

1.1 Introduction

8

1.2 Kinetic Theory of Protein Aggregation

9

1.2.1 Fundamental Processes in Protein Aggregation

9

1.2.2 The Master Equation: Quantifying the Kinetics of Aggregation

11

1.2.3 Principal Moments and Moment Equations

14

1.2.3.1 Principal Moments

14

1.2.3.2 Moment Equations

15

1.2.3.3 Common Approximations

15

1.2.4 Solving the Moment Equations: The Fixed-Point Method

17

1.2.5 Implications from Integrated Rate Laws

18

1.2.5.1 Early-Time Behaviour is Exponential

19

1.2.5.2 Half-Times and Scaling Exponents

20

1.3 The Full Aggregation Network: Interplay and Competition

21

1.3.1 Monomer Dependence of the Scaling Exponent as a Guide to Complex Mechanisms

21

1.3.2 Saturation: Processes in Series

23

1.3.2.1 Multi-step Elongation

24

1.3.2.2 Multi-step Primary Nucleation

26

1.3.2.3 Multi-step Secondary Nucleation

26

1.3.3 Competition: Processes in Parallel

27

1.3.3.1 Competition Between Primary and Secondary Processes

28

1.3.3.2 Two Competing Secondary Processes

28

1.3.4 Representing the Reaction Network

29

1.4 Application to Experiment: Global Fitting of Kinetic Data

31

1.5 Controlling Aggregation: Inhibitors and Solution Conditions

32

1.6 Conclusions

35

References

36

2 Peptide Self-Assembly and Its Modulation: Imaging on the Nanoscale

40

Abbreviations

40

2.1 Introduction

41

2.2 Peptide Self-Assembly Structures on Surfaces

42

2.3 Mutation/Modification Effects on Peptide Assemblies

45

2.4 Coassembly of Peptides with Small Molecules

49

2.4.1 Small Molecules Interacting with the Termini of Peptides

49

2.4.2 Small Molecules Interacting with the Side Groups of Peptides

52

2.5 Correlation of Peptide Assemblies on Surfaces and in Solution

56

2.6 Conclusions and Perspectives

59

References

59

3 The Kinetics, Thermodynamics and Mechanisms of Short Aromatic Peptide Self-Assembly

66

3.1 Introduction

67

3.2 The Nature of the Interactions Responsible for Peptide Assembly

68

3.2.1 Hydrogen Bonding

68

3.2.2 Hydrophobicity

70

3.2.3 Aromaticity in Proteins and Short Peptides

71

3.3 The Role of Phenylalanine Residues in Peptide Self-Assembly into Amyloid Fibrils

73

3.4 Experimental Methods to Study Short Peptide Assembly

74

3.4.1 The Choice of the Assembly Conditions for Self-Assembly

74

3.4.2 Microscopic Methods

76

3.4.3 Spectroscopic Methods

76

3.4.4 Scattering, Rheological, Calorimetric and Conductivity-Based Methods

77

3.4.5 Microfluidics

78

3.5 Thermodynamic Stability of Peptide Assemblies

79

3.5.1 Thermal Stability of FF Crystals

79

3.5.2 Chemical Stability of FF Crystals

80

3.5.3 Non-crystalline Short Aromatic Peptide Assemblies

81

3.5.3.1 Fibrils and Gels

81

3.5.3.2 Amorphous Materials

84

3.6 Mechanistic and Kinetic Description of Aromatic Peptide Assembly

87

3.6.1 Growth Processes

87

3.6.2 Nucleation Processes

90

3.7 Structure of Dipeptide Crystals with Particular Emphasis on FF

92

3.7.1 Hydrophobic Structures in Aromatic Dipeptides

93

3.7.2 Hydrogen Bond Connectivity in Aromatic Dipeptides

93

3.7.3 Macroscale Aggregate Structure

96

3.8 Comparison with the Assembly of Longer Sequences into Amyloid Fibrils

97

3.8.1 Structural Comparison

97

3.8.2 Comparison of Assembly Kinetics and Thermodynamics of Short Aromatic Peptides and Longer Amyloid Forming Sequences

101

3.9 Conclusions and Future Perspectives

106

References

107

4 Bacterial Amyloids: Biogenesis and Biomaterials

118

4.1 Introduction

119

4.2 The Curli System: Quality-Conscious and Made to Last

119

4.2.1 The Partnership of CsgB and CsgA: An Anchor for a Roving Sailor

121

4.2.2 All in the Fibril Family: Cooperation Within the Curli Operon

122

4.2.3 Younger Kid on the Block: Fap Fimbria Are Composed of Mainly FapC

124

4.2.4 Another Study in Team-Work: The Role of Fap Proteins

125

4.2.5 Other Bacterial Amyloid Systems

127

4.2.5.1 TasA: Cell Anchoring and Susceptibility to D-Amino Acids

127

4.2.5.2 MspA: The First Archaeal FuBA

132

4.2.5.3 Harpins: Green Oligomeric Weapons

132

4.2.5.4 Chaplins: Breaking the Air-Water Interface Barrier

132

4.2.5.5 Phenol-Soluble Modulins (PSM): Amyloid or Antimicrobial Agents?

133

4.3 Functional Amyloids in silico

133

4.3.1 Predicting Aggregation and Amyloid Propensity of Proteins Based on Sequences

133

4.3.1.1 Secondary Structure Propensity and Physico-Chemical Properties of Amino Acids

137

4.3.1.2 Statistical Potentials

137

4.3.1.3 Statistical Mechanical Models

138

4.3.1.4 Experimentally Driven Methods

139

4.3.1.5 Machine Learning Methods

139

4.3.1.6 Consensus Predictors

140

4.3.2 Detecting Amyloid Prone Sequences in Functional Amyloids

140

4.3.2.1 Sequence-Based Methods Can Detect Amyloidogenic Segments in Biofilm-Associated Proteins

140

4.3.2.2 Searching for Prion-like Domains Can Uncover Previously Unknown Functional Amyloids

140

4.3.2.3 The Existence of Imperfect Repeats Is Common to Many Functional Amyloids

141

4.3.3 Identifying Functional Amyloids Based on Their Evolved Characteristics

141

4.3.3.1 Searching for Functional Amyloid Homologues in Large Sequence Databases Reveals Functional Amyloid Sequence Diversity, Phylogeny, and Operon Structure

142

4.3.3.2 Techniques Targeting Evolved Characteristics May Find Unknown Functional Amyloids

143

4.3.4 Structure Prediction and Simulations of Functional Amyloids

144

4.3.4.1 Molecular Modeling Techniques Can Propose Structural Models of Functional Amyloids without Experimental Structural Data Using Evolutionary Constraints

144

4.3.4.2 Simulation Can Help to Elucidate the Molecular Details of Functional Amyloid Formation

145

4.4 Uses for Functional Amyloid: Brave New Nanomaterials

146

4.4.1 C-DAG as a Screen for Amyloid: How to Hijack a Robust Amyloid Export System

146

4.4.1.1 Generating New Binding Properties: How to Hitch a Ride on the Amyloid Ladder

147

4.4.1.2 Amyloid as Underwater Glue: Fusing CsgA to Mussel Foot Proteins

148

4.4.1.3 Controlled Combination of Different Amyloid: The Power of Riboregulators

148

4.4.2 Controlling Amyloid with Co-Factors: The Case of the Missing Calcium

150

4.4.3 Inclusion Bodies with Tunable Porosity: Nanopills for Drug Delivery?

151

4.4.4 Other Amyloid Uses: From Macroscale Films to Bone Replacement and Tissue Engineering

151

4.5 Perspectives

152

4.5.1 Challenges in the Development of New Amyloid-Based Biomaterials and -Medicine

153

References

154

5 Fungal Hydrophobins and Their Self-Assembly into Functional Nanomaterials

165

5.1 Introduction

166

5.2 The Discovery of Hydrophobins

166

5.3 Class I and Class II Hydrophobins

168

5.4 Structures of Class I and Class II Hydrophobins

170

5.5 The Surface Activity of Hydrophobins

171

5.6 Mechanism of Hydrophobin Assembly from Monomer to Amphipathic Monolayer

172

5.7 Hydrophobins Have Multiple Functions in the Fungal Life Cycle

175

5.7.1 Hydrophobin Coatings Shield Fungal Structures from Host Immune Recognition

175

5.7.2 Hydrophobins Facilitate Attachment of Fungi to Host Cells for Colonisation

177

5.8 Harnessing Hydrophobins for Biotechnological Purposes

177

5.8.1 Hydrophobins Used to Modify or to Functionalise Surfaces

178

5.8.2 Hydrophobins Used to Coat Stents for Anti-Fouling Properties

181

5.8.3 Hydrophobins Used to Stabilise Emulsions

181

5.8.4 Hydrophobins Applied for Improved Drug Delivery

182

5.9 Conclusions

183

References

184

6 Nanostructured, Self-Assembled Spider Silk Materials for Biomedical Applications

190

6.1 Introduction

190

6.2 Natural Spider Silk

191

6.2.1 Protein Composition of Major Ampullate Silk

192

6.2.2 Processing of Spider Silk Proteins into Fibers

193

6.2.3 Structure-Mechanics Relationships

194

6.3 Recombinant Spider Silk Proteins

197

6.3.1 Self-Assembly of Artificial Spider Silk Proteins

197

6.3.2 Materials Made of Recombinant Spider Silk Proteins

199

6.3.2.1 Nanofibrils

199

6.3.2.2 Hydrogels

203

6.3.2.3 Particles

203

6.3.2.4 Capsules

203

6.3.2.5 Films

204

6.3.2.6 Foams and Sponges

204

6.4 Biomedical Applications of Spider Silk

205

6.4.1 Drug Delivery and Deposition

206

6.4.2 Tissue Engineering

207

6.4.2.1 Wound Healing Scaffolds

208

6.4.2.2 Bone Tissue Engineering

209

6.4.2.3 Nerve Tissue Engineering

210

6.4.2.4 Implant Coating

211

6.5 Biofabrication

212

6.6 Conclusions

214

References

214

7 Protein Microgels from Amyloid Fibril Networks

225

7.1 Nature of Amyloid Proteins

226

7.1.1 Introduction

226

7.1.2 Detection of Amyloid Structures

229

7.1.3 Structure of Amyloid Fibrils

229

7.1.4 Self-Assembly and Polymorphism of Amyloid Fibrils

231

7.1.5 Mechanical Properties of Amyloid Fibrils

232

7.2 Amyloid Proteins for the Development of Functional Microgels

234

7.2.1 Emerging Applications of Artificial Amyloid Protein-Based Materials and Microgels

234

7.2.1.1 Amyloid Microgels as Drug Carrier Agents

235

7.2.2 Microgel and Microcapsule Formation

236

7.2.2.1 Microgel Formation Techniques

236

7.2.2.2 Structural Changes Accompanying the Formation of Protein Microgels and Protein Microgel Stability

239

7.2.3 Case Study: The Development of Protein Microgels and Gel Shells from Amyloid Fibril Networks as Drug Carrier Agents

241

7.2.4 Multiphase Protein Microgels – Phase Separation Phenomenon in Microgels

245

7.2.5 Microgels from All-Aqueous Emulsions Stabilized by Amyloid Nanofibrils

247

7.2.6 Functionalized Proteinaceous Microgels

250

7.3 Conclusions

253

References

253

8 Protein Nanofibrils as Storage Forms of Peptide Drugs and Hormones

266

8.1 Introduction

266

8.2 Functional Amyloids

269

8.3 Amyloids as a Depot for Protein/Peptide Storage and Release

269

8.4 Amyloid as Long-Acting Depot Formulations

277

8.5 Conclusion

284

References

285

9 Nanozymes: Biomedical Applications of Enzymatic Fe3O4 Nanoparticles from In Vitro to In Vivo

292

Abbreviations

292

9.1 Introduction

293

9.2 Basic Features of Fe3O4 Nanozymes

294

9.2.1 Activities of Fe3O4 Nanozymes

294

9.2.2 Kinetics and Mechanism of Fe3O4 Nanozymes

295

9.2.3 Advantages of Fe3O4 Nanozymes

296

9.3 Biomedical Applications of Fe3O4 Nanozymes

298

9.3.1 In Vitro Bioassays

298

9.3.2 Ex Vivo Tracking and Histochemistry Diagnosis

300

9.3.3 In Vivo Oxidative Stress Regulation

302

9.3.4 Hygiene and Dental Therapy

305

9.3.5 Eco Environment Applications

306

9.4 Summary and Future Perspectives

307

References

308

10 Self-Assembly of Ferritin: Structure, Biological Function and Potential Applications in Nanotechnology

314

10.1 Introduction

315

10.2 Historical Perspective

315

10.3 Ferritin: Basic Biology

317

10.4 Ferritin Protein Family

318

10.5 Structure of Ferritin

320

10.6 Application of Ferritin in Nanotechnology

322

10.7 Drug Delivery and Ferritin

323

10.8 Surface Modification and Cellular Interactions of Ferritin Nanoparticles

324

10.9 Other Potential Applications of Ferritin

325

10.10 Conclusions and Future Perspectives of Ferritin in Nano-biology

326

References

327

11 DNA Nanotechnology for Building Sensors, Nanopores and Ion-Channels

331

11.1 Self-Assembly with DNA

332

11.1.1 DNA Lattices and Tiles

332

11.1.2 DNA Origami

334

11.1.3 Design and Assembly of DNA Nanostructures

336

11.1.3.1 Conceiving the Target Shape

336

11.1.3.2 Crossover Rules for DNA Nanostructures

337

11.1.3.3 Computational Tools for DNA Nanotechnology

338

11.1.3.4 Assembly and Stability of DNA Nanostructures

340

11.1.4 Experimental Characterisation of DNA Nanostructures

341

11.1.4.1 UV-Vis Spectroscopy

341

11.1.4.2 UV Melting Profile

341

11.1.4.3 Gel Electrophoresis

342

11.1.4.4 Dynamic Light Scattering

343

11.1.4.5 AFM and TEM

344

11.1.4.6 DNA-PAINT

345

11.1.4.7 Functionalisation of DNA

345

11.2 DNA Sensors and Nanopores

346

11.2.1 Nanomechanical DNA-Based Sensors

347

11.2.1.1 Molecular Sensors

347

11.2.1.2 Environmental Sensors

348

11.2.2 Nanopores for Single-Molecule Detection

348

11.2.3 DNA Nanotechnology for Enhanced Nanopore Sensing

350

11.2.4 DNA Origami Hybrid Nanopores

352

11.2.4.1 Nanopore Architecture By Design

353

11.2.4.2 Tunable Pore Diameter

353

11.2.4.3 High Specificity

353

11.2.4.4 Stimuli Response

354

11.2.4.5 Ease of Fabrication

354

11.3 Synthetic Membrane Nanopores

355

11.3.1 Membrane Pores in Nature

356

11.3.2 Milestones of Synthetic Membrane Pores

357

11.3.3 DNA-Based Membrane Pores

359

References

362

12 Bio Mimicking of Extracellular Matrix

371

Abbreviations

371

12.1 Introduction

372

12.2 The Extracellular Matrix

373

12.3 Classification of Biomaterials

374

12.4 Synthetic Biomaterials

375

12.4.1 Metallic Biomaterials

375

12.4.2 Ceramic Biomaterials

377

12.4.3 Synthetic Biodegradable Polymers

379

12.5 Natural Biomaterials

380

12.5.1 Collagen

380

12.5.2 Alginate

382

12.5.3 Cellulose

384

12.5.4 Chitin-Chitosan

384

12.6 Natural and Synthetic Composite Biomaterials

385

12.7 Supramolecular Soft Biomaterials (Hydrogels)

386

12.8 How to Design the Molecular Building Blocks for Hydrogels

386

12.8.1 Mimicking the Microarchitecture of the Native ECM with Engineered Scaffolds

386

12.8.2 Microarchitecture of Tissue-Engineered Scaffolds

387

12.9 Hydrogel Degradation

389

12.10 Bioadhesion and Bioactivity

389

12.11 3D Structures of Hydrogels

390

12.12 Conclusions

391

References

392

13 Bioinspired Engineering of Organ-on-Chip Devices

400

Abbreviations

401

13.1 Introduction

401

13.2 Microfluidic Cell Culture System

402

13.3 Microengineering the Cellular Microenvironment

404

13.3.1 Cell-Matrix Interaction

405

13.3.2 Cell-Cell Interactions

405

13.3.3 Control of Biochemical Microenvironments

406

13.3.3.1 Gradients of Soluble Factors

406

13.3.3.2 Control of Oxygen Concentration

407

13.3.4 Control of Biophysical Microenvironments

408

13.3.4.1 Fluid Flow-Induced Stress

408

13.3.4.2 Tissue Mechanics

409

13.4 From Cells-on-Chip to Organs-on-Chips

409

13.4.1 Bioengineering Organs on Chip

414

13.4.1.1 Lung on a Chip

414

13.4.1.2 Gastrointestines on a Chip

415

13.4.1.3 Liver on a Chip

417

13.4.1.4 Heart on a Chip

418

13.4.1.5 Blood-Brain-Barrier on Chip

419

13.4.1.6 Multiple Organs on a Chip

419

13.4.2 Integrated Analysis System

421

13.5 Proof-of-Concept Applications of Organs-on-Chip

422

13.5.1 Disease Modeling

422

13.5.1.1 Inflammatory-Related Diseases

422

13.5.1.2 Brain diseases on Chip

423

13.5.1.3 Cancers on Chip

424

13.5.2 Drug Testing

425

13.5.2.1 Efficacy and Toxicity Testing

425

13.5.2.2 Pharmacokinetic and Pharmacodynamic Studies

427

13.5.3 Host-Microbe Interaction

429

13.6 Conclusion and Outlooks

430

References

431